Vidcast: https://www.instagram.com/p/DZ16HR9ymr-/

Millions of Americans take glucosamine daily for the joint pain of arthritis. New research from University of Florida raises questions about its safety. Published in the journal Nature Metabolism, regular consumption of glucosamines is associated with faster progression of Alzheimer’s disease.

The researchers analyzed health records from thousands of patients using artificial intelligence. After accounting for factors such as age, sex, and demographics, they find that glucosamine users with mild cognitive impairment have a 25 percent higher likelihood of progressing to dementia compared with non-users. The study finds only an association and does not prove that glucosamine causes these outcomes.

To understand what could be happening, the scientists examined brain tissue and conducted experiments in mouse models of Alzheimer’s disease. They discovered that glucosamine appears to increase a biological process that adds sugar molecules to proteins. This sugar-tagging system is already overactive in Alzheimer’s brains, and accelerating it may contribute to disease progression with memory decline. When researchers reduce the activity of this pathway, memory performance improves. Similar abnormalities are also found in human Alzheimer’s brain tissue.

The investigators emphasize that people should not panic or stop medications based solely because of this study. Clinical trials will be needed to determine whether glucosamine truly contributes to Alzheimer’s progression or whether other factors are involved.

Still, the findings highlight how supplements that seem harmless may have unexpected effects in people with certain medical conditions. If you or a loved one takes glucosamine and has memory issues, this study may be worth discussing with a healthcare professional.

The references for this report are available on my website.

#Alzheimers #BrainHealth #Glucosamine #DementiaResearch #HealthNews

Vidcast: https://www.instagram.com/p/DZ15Z-atOYA/

A simple, home-based exercise program helps reduce the cognitive problems often called “chemo brain.” This according to new research from the University of Rochester’s Wilmot Cancer Institute published in the journal Cancer.

The problem is common. Brain fog symptoms affect up to 80 percent of people receiving chemotherapy and include memory lapses, trouble concentrating, and difficulty multitasking.

The researchers enrolled 86 cancer patients undergoing chemotherapy and reporting cognitive difficulties. Participants were assigned to one of four groups: exercise plus placebo, exercise plus low-dose ibuprofen, ibuprofen alone, or placebo alone. The exercise program, called EXCAP, combined progressive walking with light resistance exercises that patients performed at home.

After six weeks, patients in the exercise group show significantly better attention on cognitive tests compared with those receiving placebo. Friends, family members, and coworkers also notice fewer cognitive problems among participants who exercised.

The low-dose ibuprofen produces benefits as well. Patients taking ibuprofen alone show improvements in attention compared with placebo. However, these benefits are less consistent, and researchers find that some measures of short-term verbal memory improve less among ibuprofen users.

The bottom line: the strongest overall benefits come from exercise. This finding is particularly encouraging because physical activity already provides many other health benefits for people undergoing cancer treatment and recovery.

Larger Phase III trials will be needed to confirm the results. Even now, though, the findings suggest that something as simple as regular walking and light resistance exercise may help protect brain function during chemotherapy.

The references for this report are available on my website.

#CancerResearch #ChemoBrain #CancerSurvivor #BrainHealth #ExerciseMedicine

Vidcast: https://www.instagram.com/p/DZ14xIxpKpJ/

That neurotransmitter is acetylcholine according to new research from Japan’s Okinawa Institute of Science and Technology. It is involved in learning, memory, and decision-making, and it helps us abandon old habits and adapt when things don’t go as expected.

In a their study published in Nature Communications, researchers trained mice to navigate a virtual maze where they learned which path led to a reward. Once the mice became comfortable with the routine, scientists suddenly changed the rules and removed the expected reward. When mice experience this disappointment, researchers observe a surge of acetylcholine in key brain regions.

This spike appears to trigger behavioral flexibility. Mice with larger increases in acetylcholine are more likely to stop repeating an old strategy and try a new one. In other words, disappointment seems to activate a brain signal that encourages change instead of repetition.

To test the idea further, researchers reduced the mice’s ability to produce acetylcholine. The result was striking. The animals become less flexible and are more likely to stick with outdated choices even when those strategies no longer work.

This discovery helps explain why some conditions make it difficult to break habits. Disorders such as addiction, obsessive-compulsive disorder, and Parkinson’s disease are often characterized by behavioral inflexibility. Understanding how acetylcholine helps the brain adapt could eventually lead to new treatment approaches for these disorders.

The next time something doesn’t go your way, know that your brain may already be using that disappointment as a signal to explore a better path.

The references for this report are available on my website.

#BrainHealth #Neuroscience #Acetylcholine #MentalHealth #ScienceNews

Vidcast: https://www.instagram.com/p/DZ14J55SUBS/

This new drug, in contrast to our current, popular diet medications, doesn’t curb your appetite but rather works on your body’s muscles to intensify fat burning and blood sugar control.

Karolinska Institute molecular biologists, publishing in the journal Cell, show that their laboratory-designed beta-2 agonist activates metabolic pathways inside muscle tissue. In animal studies, this leads to improved blood sugar regulation, increased fat burning, and healthier body composition. Unlike the GLP-1 weight-loss drugs, the treatment does not appear to cause appetite suppression, muscle loss, or digestive side effects.

The research team also completed an preliminary Phase I clinical trial involving 48 healthy volunteers and 25 people with type 2 diabetes. The treatment is safe and well tolerated.

The researchers say preserving muscle mass may be the most important benefit of this alternative weight loss regimen because muscle plays a major role in metabolism, healthy aging, and overall life expectancy.

Another potential advantage is convenience. Unlike some GLP-1 medications, that require injection, this therapy is an oral medication. The scientists also believe it could eventually be used either alone or alongside existing drugs such as Ozempic and Wegovy.

At this time, beta-2 agonist therapy remains experimental though a larger Phase II trial is now planned. The question of the day: could future weight-loss treatments focus on selectively boosting metabolism instead of suppressing appetite? Upcoming studies should provide an answer.

The references for this report are available on my website.

#DiabetesResearch #WeightLossNews #ObesityResearch #HealthyAging #MedicalBreakthrough

Vidcast: https://www.instagram.com/p/DZ13S0eOGtH/

Some of the fats we eat nourish cancer while others help our immune systems kill it. Oncologists at the Yale School of Medicine report in the American Association For Cancer Research journal that, for pancreatic cancer in a mouse model, the fat in olive oil accelerates cancer growth while fish oils slow that growth.

Mice fed diets rich in oleic acid develop pancreatic tumors faster than mice on other diets. This was unexpected because oleic acid has long been considered heart-healthy and is commonly found in olive oil, peanuts, lard, and certain sunflower and safflower oils.

On the other hand, omega-3 fats found in fish oil had the opposite effect. Mice fed fish-oil-enriched diets experience about a 50 percent reduction in disease compared with mice eating a standard-fat diet. The researchers find that omega-3 fats make cancer cells more vulnerable to a natural self-destruct process called ferroptosis. Monounsaturated fats like oleic acid appeared to protect cancer cells from that process.

The team also finds that higher ratios of monounsaturated fats to polyunsaturated fats are linked to greater pancreatic cancer burden, while lower ratios are associated with less cancer development. A side note: the tumor-promoting effects of oleic acid are much stronger in male mice than in female mice.

This study was conducted in mice, not humans, and more research is needed before any dietary recommendations can be made. However, the findings may eventually help people at higher risk for pancreatic cancer understand how specific dietary fats influence disease development and progression.

The references for this report are available on my website.

#PancreaticCancer #CancerResearch #YaleMedicine #Omega3 #HealthNews

Vidcast: https://www.instagram.com/p/DZ12lZrsF0g/

Ever hear of the thymus? Most people haven’t. But Mass General Brigham scientists now report in the journal Nature that this tiny immune-system organ may be one of the strongest hidden predictors of longevity, disease risk, and even cancer treatment success.

The radiology researchers used artificial intelligence to analyze CT scans from more than 25,000 adults to create a “thymic health score” based on the organ’s size, structure, and composition. People with healthier thymuses had about a 50% lower risk of death from any cause, a 63% lower risk of dying from cardiovascular disease, and a 36% lower risk of developing lung cancer. The data shows that smoking, chronic inflammation, and higher body weights were associated with poorer thymus health.

Looking at a subgroup of more than 1,200 cancer patients receiving immunotherapy, those with healthier thymuses had a 37% lower risk of cancer progression and a 44% lower risk of death compared with patients who had poorer thymic health.

Your immune system plays a much larger role in healthy aging than many people realize. Understanding how the thymus changes over time could eventually help doctors identify disease risks earlier and develop new strategies to support immune health as we age.

The references for this report are available on my website.

#Longevity #ImmuneSystem #HealthyAging #CancerResearch #MedicalResearch

Vidcast: https://www.instagram.com/p/DZ12A89B8Oj/

Occidental College and the University of California, Irvine ophthalmologists are developing a futuristic alternative to LASIK that promises to correct your blurry vision without cutting, burning, or removing any eye tissue.

This novel process called electromechanical reshaping or EMR uses tiny electrical pulses and a special 3D printed contact mold to reshape eye tissues. By sending a very low electrical current through the custom platinum contact lens on the cornea, its molecular bonds loosen enough to permit a strategic tissue reshaping. Once the current is turned off, the cornea stiffens again and locks into the new form that better focuses images on the retina.

This technique successfully corrects the nearsightedness of rabbits eyes in about one minute. The rabbits’ corneal cells remain alive and healthy. Additional animal studies are currently underway to test the procedure for correction of farsightedness, astigmatism, and corneal clouding due to chemical damage. Much research lies ahead before it can undergo clinical trials.

Though the LASIK procedure has helped millions of people, it does permanently remove some corneal tissue and has sometimes leads to dry eyes, glare, halos, or other complications. This new approach might potentially preserve more of the eye’s natural strength while reducing cost and invasiveness.

The references for this report are available on my website.

#VisionCorrection #LASIK #EyeHealth #MedicalInnovation #FutureMedicine

Vidcast: https://www.instagram.com/p/DZ11YIRNMh_/

You may have fatty liver disease and not even realize it. University of California, San Diego hepatology researchers, those scientists who specialize in liver research, now say that a new experimental treatment could help stop the damage before it leads to liver failure, cirrhosis, liver cancer, and/or the need for a difficult to obtain liver transplant.

They report in The Lancet that an experimental drug called ION224 suppresses a liver enzyme that allows the liver produce and store excessive fat, a process that drives inflammation, scarring, and long-term damage. They drug halts the destructive process rather than merely managing symptoms.

The investigators conducted a Phase 2 clinical trial involving 160 adults with so-called MASH, a severe form of fatty liver disease linked to obesity and type 2 diabetes which can progress silently. The participants received monthly injections of ION224 over 51 weeks.

Patients receiving the highest dose showed the best results, with about 60% of participants experiencing meaningful improvements in liver health compared with those controls receiving a placebo. The drug was well tolerated with no serious side effects linked to the treatment.

More than 100 million Americans are believed to have some form of fatty liver disease, and many don’t know it until significant damage has already occurred. A treatment that directly targets liver fat accumulation offers a new way to slow, halt, or potentially reverse disease progression. This therapy is still experimental and must successfully complete larger Phase 3 randomized, trials before it can receive regulatory approval and become available to your medical team.

The references for this report are available on my website.

#FattyLiverDisease #LiverHealth #MASH #MedicalResearch #HealthyAging